Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia

NCT03172702 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca